No Detail Found!

Bloodstream infections in patients undergoing extracorporeal membrane oxygenation

Author(s)
Jian-rong Wang Department of Critical Care MedicineThe Affiliated Hangzhou Hospital of Nanjing Medical University, Zhejiang, China.
Jin-yu Huang Department of Cardiology,The Affiliated Hangzhou Hospital of Nanjing Medical University, Zhejiang, China.
Wei Hu Department of Critical Care Medicine, The Affiliated Hangzhou Hospital of Nanjing Medical University, Zhejiang, China.
Xue-ying Cai Department of Critical Care Medicine, The Affiliated Hangzhou Hospital of Nanjing Medical University,Zhejiang, China.
Wei-hang Hu Department of Critical Care Medicine, Zhejiang Hospital, Zhejiang, China.
Ying Zhu Department of Critical Care Medicine The Affiliated Hangzhou Hospital of Nanjing Medical University, Zhejiang, China.
Abstract
Objective: We aimed to evaluate the incidence, risk factors, and prognosis of bloodstream infections (BSIs) during extracorporeal membrane oxygenation (ECMO) treatment in a Chinese population. Methods: Patients receiving ECMO treatment from January 2013 to August 2019 were retrospectively studied. The incidence of BSIs was calculated. The clinical characteristics between patients with a BSI (BSI group) and without a BSI (non-BSI group) Results: Among 69 included patients, 19 (27.5%) developed at least one BSI. Gram-negative bacteria (73.7%) were mainly responsible for the BSIs, with Klebsiella pneumoniae (6/19, 31.5%) ranking as the top related pathogen. The BSI group had a greater proportion of methicillin-resistant Staphylococcus aureus (MRSA) prophylactic regimens (52.6% vs. 26.0%, P = 0.036), a higher pre-ECMO Sequential Organ Failure Assessment (SOFA) score (11 vs. 8, P = 0.008), more applications of continuous renal replacement therapy (CRRT) during ECMO (63.1% vs. 36.1%, P = 0.042). Longer ECMO support duration, period of ventilator use before ECMO weaning and hospital stay were observed in the BSI group. The SOFA score (OR: 1.174; 95% CI: 1.039-1.326; P = 0.010) was an independent risk factor for BSIs. Conclusion: BSIs during ECMO therapy frequently involve Gram-negative bacteria. Stringent care and monitoring should be provided for patients with high SOFA scores.
Publication Details
Page(s) 1171-1176
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 36, Issue: 6, Year: 2020

Request the full text from PASTIC

0

Citations

0

Downloads

114

Views